Original ArticleClinical Research: TherapeuticsIxekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque Psoriasis
Clinical Research: Therapeutics
Under a Creative Commons license
open access
Abbreviations
ADA
anti-drug antibody
nADA
neutralizing anti-drug antibody
PASI
Psoriasis Area and Severity Index
PK
pharmacokinetics
Q2W
every 2 weeks
Q4W
every 4 weeks
TE-ADA
treatment-emergent anti-drug antibody
Cited by (0)
© 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.